Allergy Clinical Trial
— ABCFish2Official title:
Protists and Nematodes Fish Parasites: From Their Circulation in Ecosystems to Their Impact on Human Health - Role of Anisakidae and/or Fish Flesh Antigens in Fish Allergies.
Verified date | January 2017 |
Source | University Hospital, Lille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Anisakidae frequently infect fish species that are commonly eaten by humans. Some of them
are recognized as zoonotic diseases agents, and have a high impact on human health.
Infestation results from the ingestion of living larvae from contaminated fishes. It can be
asymptomatic or symptomatic, resulting in acute gastric, acute intestinal or chronic forms.
Allergic manifestations are frequently encountered in gastric forms, but allergic symptoms
can also occur in isolation, after ingestion of Anisakidae antigens contained in raw or
cooked fish, and may masquerade as fish allergy.
In this study, we aim to characterize the relationship between Anisakidae and/or fish
sensitization and the presence of allergic manifestations in patients recruited in the
general population and presenting fish allergy resulting from ingestion, cutaneous or
respiratory contact. We will also determine the respective role of Anisakidae or fish
sensitization in patients with fish allergy. Then, we will determine the prevalence of
previous Anisakidae infections among these patients and a matched control population. We
will also compare the performances of serological tests (ImmunoCAP, immunoelectrophoresis
and Western Blot) for the diagnosis of Anisakidae allergy or infection. Lastly, we will
explore the relationship between domestic exposure to Anisakidae or fish antigens and the
occurrence of associated pathologies (Anisakidae or fish allergy/sensitization; Anisakidae
infection).
Status | Completed |
Enrollment | 105 |
Est. completion date | January 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: ALLERGIC PATIENTS: - Previous serological assessment for anti-Anisakis or anti-fish antibodies detection (ImmunoCap and/or immunoelectrophoresis) in Lille University Hospital Center, and volume of serum conserved =500 µl - Allergic manifestations after contact with fish (asthma, allergic rhinitis, conjunctivitis, chronic or acute urticaria, dermatitis/eczema, eosinophilic gastroenteritis, gingivostomatitis, angioedema, bronchospasm, anaphylaxis) CONTROL SUBJECTS: - Serological assessment for infectious disease during a routine occupational health consultation in Lille University Hospital Center - Absence of fish allergy Exclusion Criteria: - Pregnant or breast-feeding female - Patient with no social insurance - Patient unwilling to comply with the protocol - Patient unable to understand the study and its objectives - Patient under guardianship |
Country | Name | City | State |
---|---|---|---|
France | CHRU | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille | ANSES, Boulogne-sur-Mer, Hôpital Cochin, Institut Pasteur de Lille, Région Nord-Pas de Calais, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the frequency of anti-Anisakis and/or anti-fish IgE by serum analysis | comparison between subjects with fish allergy and a matched control population, presenting no fish allergy. | contact by phone during 30 min at only visit (inclusion) | |
Secondary | anti-Anisakis and/or anti-fish IgE level by serum analysis | Comparison between subjects with fish allergy and a matched control population, presenting no fish allergy. | contact by phone during 30 min at only visit (inclusion) | |
Secondary | the frequency of anti-Anisakis and anti-fish IgE in patients with fish allergy by serum analysis | contact by phone during 30 min at only visit (inclusion) | ||
Secondary | nomber of subjects of previous Anisakidae infections | questionnaire-based diagnosis, supported by serological testing between patients with fish allergy and a matched control population, presenting no fish allergy. | contact by phone during 30 min at only visit (inclusion) | |
Secondary | Measure of the performances of serological tests | Comparison of the performances of serological tests (ImmunoCAP, immunoelectrophoresis and Western Blot) for the diagnosis of Anisakidae allergy or infection. | at work medical visit (inclusion) | |
Secondary | The frequency of domestic exposure to fish parasites antigens by questionnaire | It will be compared between Anisakis or fish allergic/sensitized subjects and non-allergic/non sensitized subjects. It will be compared between patients with or without previous Anisakidosis. Fish exposure will be determined taking into account the handled fish species and the local prevalences of fish parasites. |
contact by phone during 30 min at only visit (inclusion) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02032056 -
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
|
N/A | |
Completed |
NCT01842711 -
Cumulative Irritation Patch Test
|
N/A | |
Completed |
NCT01633840 -
New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges
|
N/A | |
Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
Completed |
NCT00554983 -
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
|
Phase 3 | |
Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
Completed |
NCT00220753 -
Air Cleaners for Children and Adolescents With Asthma and Dog Allergy
|
N/A | |
Completed |
NCT00232518 -
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
|
N/A | |
Completed |
NCT04046731 -
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
|
N/A | |
Completed |
NCT04126096 -
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
|
N/A | |
Completed |
NCT04004351 -
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
|
||
Not yet recruiting |
NCT05997784 -
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
|
||
Completed |
NCT04418999 -
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
|
Early Phase 1 | |
Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
Completed |
NCT02127801 -
Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants
|
Phase 1 | |
Enrolling by invitation |
NCT05011071 -
The Alberta BLOOM Premature Child Study
|
||
Not yet recruiting |
NCT06330974 -
Allergy, Asthma, and Atopic Eczema in Finland
|
||
Terminated |
NCT02601690 -
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
|
||
Completed |
NCT02596321 -
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
|
Phase 3 | |
Completed |
NCT02306473 -
The Leaky Lung Test
|
Early Phase 1 |